Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
SCIELE PHARMA, INC. (SCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/10/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/03/2009 SC 13G/A BARCLAYS GLOBAL INVESTORS NA reports a 0% stake in SCIELE PHARMA INC
10/09/2008 8-K Quarterly results
09/03/2008 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Agreement and Plan of Merger, among Shionogi & Co., Ltd., Tall Bridge, Inc. and Sciele Pharma, Inc.",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Patrick Fourteau",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Edward Schutter",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Darrell Borne",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Leslie Zacks",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Larry Dillaha",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Joseph Ciaffoni",
"SHIONOGI & CO., LTD. TO ACQUIRE SCIELE PHARMA, INC. SIGNIFICANTLY INCREASES SHIONOGI'S PRESENCE IN THE UNITED STATES",
"Form of Tender and Voting Agreement"
08/27/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Agreement between the Company and Joseph Ciaffoni"
08/18/2008 4 FOURTEAU PATRICK (CEO) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Exercised 100,000 shares @ $0
Sold 100,000 shares @ $21.3739, valued at $2.1M
Exercised 50,000 options @ $11.455, valued at $572.8k
08/12/2008 4 Dillaha Larry (EVP and Chief Medical Officer) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Sold 875 shares @ $20.336, valued at $17.8k
07/31/2008 10-Q Quarterly Report for the period ended June 30, 2008
07/30/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR THE SECOND QUARTER OF 2008 Second quarter 2008 financial results include:"
07/30/2008 TRN Sciele Pharma Inc. Q2 2008 Earnings Call Transcript
07/01/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA SIGNS AGREEMENT WITH ADDRENEX PHARMACEUTICALS TO DEVELOP AND MARKET ADX415 FOR THE TREATMENT OF HYPERTENSION"
05/28/2008 4 SAXE JON S (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Exercised 3,750 shares @ $0
Sold 3,750 shares @ $21.08, valued at $79.1k
Exercised 3,750 options to buy @ $18.917, valued at $70.9k
05/28/2008 4 LAPALME PIERRE (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Exercised 3,750 shares @ $0
Sold 3,750 shares @ $21.08, valued at $79.1k
Exercised 3,750 options to buy @ $18.917, valued at $70.9k
05/28/2008 4 ELLIS JERRY N (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Exercised 3,750 shares @ $0
Sold 3,750 shares @ $21.08, valued at $79.1k
Exercised 3,750 options @ $18.917, valued at $70.9k
05/23/2008 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Elimination"
05/19/2008 4 Zacks Leslie (EVP/Chief Legal Compl. Officer) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Sold 1,625 shares @ $21.71, valued at $35.3k
05/19/2008 4 FOURTEAU PATRICK (CEO) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Exercised 100,000 shares @ $0
Sold 100,000 shares @ $21.0761, valued at $2.1M
Exercised 50,000 options @ $11.455, valued at $572.8k
05/01/2008 10-Q Quarterly Report for the period ended March 31, 2008
04/30/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR THE FIRST QUARTER OF 2008 First quarter 2008 financial results include:"
04/30/2008 TRN Sciele Pharma, Inc. Q1 2008 Earnings Call Transcript
04/28/2008 4 Dillaha Larry (EVP and Chief Medical Officer) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Sold 350 shares @ $19.35, valued at $6.8k
04/28/2008 4 LAPALME PIERRE (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Granted 10,000 options to buy @ $0
04/28/2008 4 ZENNER PATRICK J (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Granted 10,000 options to buy @ $0
04/28/2008 4 Robinson William John (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Granted 10,000 options to buy @ $0
04/28/2008 4 ELLIS JERRY N (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Granted 10,000 options to buy @ $0
04/28/2008 4 Griffin Jerry C (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Granted 10,000 options to buy @ $0
04/28/2008 4 SAXE JON S (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Granted 10,000 options to buy @ $0
04/28/2008 8-K Material Modifications to Rights of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Sciele Pharma, Inc. Adopts $100 Million Share Repurchase Program ———————— Approves Redemption of Poison Pill"
04/03/2008 4 SCHUTTER EDWARD J (President & COO) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Sold 2,500 shares @ $20.72, valued at $51.8k
03/18/2008 4 LAPALME PIERRE (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Bought 100 shares @ $18.4101, valued at $1.8k
Bought 100 shares @ $18.44, valued at $1.8k
Bought 1,800 shares @ $18.41, valued at $33.1k
03/17/2008 4 ZENNER PATRICK J (Director) has filed a Form 4 on SCIELE PHARMA, INC.
Txns: Bought 1,100 shares @ $18.45, valued at $20.3k
Bought 500 shares @ $18.46, valued at $9.2k
Bought 400 shares @ $18.47, valued at $7.4k
Bought 500 shares @ $18.48, valued at $9.2k
Bought 1 shares @ $18.49, valued at $18.5
Bought 204 shares @ $18.5, valued at $3.8k
03/14/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ACQUIRES TWINJECT EPINEPHRINE AUTO-INJECTOR FROM VERUS PHARMACEUTICALS"
03/12/2008 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy